Huveaux PLC
17 August 2005
Not for release, publication or distribution in or into the United States,
Australia, Canada, Japan or any other jurisdiction if to do so would constitute
a violation of the relevant laws of such jurisdiction
For immediate release 17 August 2005
Epic Group plc ('Epic')
Offer update
On 27 July 2005, an £8.5 million bridge facility (the 'Bridge Facility') was
made available by the Bank of Scotland to Huveaux PLC ('Huveaux') for the
purposes of funding the cash consideration payable by Huveaux in relation to its
offer for Epic. Further details of this facility were contained in the
Equivalent Information Document which accompanied the Offer Document sent to
Epic Shareholders on 28 July 2005.
On 17 August 2005, the Bank of Scotland and Huveaux signed an amendment letter
in relation to the Bridge Facility (the 'Amendment Letter'). Amongst other
things, the Amendment Letter will allow Huveaux to declare the Offer wholly
unconditional, upon receipt of acceptances from Epic Shareholders in respect of
51 per cent. or more Epic Shares.
Copies of the Amendment Letter relating to this amendment may be inspected at
the offices of Eversheds LLP, Senator House, 85 Queen Victoria Street, London
EC4V 4JL during usual business hours on any weekday (excluding Saturdays and
public holidays) up to and including the date upon which the Offer closes.
Words and expressions defined in the Offer Document dated 28 July 2005 shall
have the same meaning when used in this announcement.
Enquiries
Huveaux 020 7245 0270
John van Kuffeler, Executive Chairman
Dresdner Kleinwort Wasserstein (Financial advisor to Huveaux) 020 7623 8000
Joe Thompson
Finsbury (Public Relations advisor to Huveaux) 020 7251 3801
James Leviton
Katie Lang
Don Hunter
Dresdner Kleinwort Wasserstein, which is authorised and regulated by the
Financial Services Authority, is acting for Huveaux and for no-one else in
connection with the Offer and will not be responsible to anyone other than
Huveaux for providing the protections afforded to customers of Dresdner
Kleinwort Wasserstein, or for providing advice in relation to the Offer or any
matters referred to herein.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.